u-72107

Pioglitazone (U 72107) is an insulin sensitizing agent and thiazolidinedione indicated for the treatment of type 2 diabetes, and has been linked to rare instances of acute liver injury.

Pioglitazone D4 is a deuterium labeled Pioglitazone. Pioglitazone is a agonist of PPARγ .

Pioglitazone potassium (U 72107) is an orally active, selective agonist of peroxisome proliferator-activated receptor gamma (PPARγ), exhibiting high-affinity binding to the ligand-binding domain of PPARγ with EC50 values of 0.93 μM for human and 0.99 μM for mouse PPARγ. It has applications in diabetes research [2] [3] [4].

(R)-Pioglitazone ((+)-pioglitazone), the R enantiomer of Pioglitazone, serves as a selective and orally active peroxisome proliferator-activated receptor (PPARγ) agonist. It exhibits high-affinity binding to the PPARγ ligand-binding domain and is utilized in research related to Alzheimers disease.